Scholars Central

Mini reviewPublished 3 Mar 2024

Defeating Diabetic Neuropathy a Comprehensive Guide

Authors: Stodt Jan

Department of Lipid Disorders, Edificio de Grado - Universidad Austral, Argentina

Journal of Clinical Diabetes

Volume 8 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetic neuropathy presents a formidable challenge in the management of diabetes mellitus, affecting millions worldwide with its debilitating symptoms and potential complications. This comprehensive guide endeavors to provide a holistic approach to defeating diabetic neuropathy, encompassing various strategies ranging from lifestyle modifications to medical interventions. The abstract begins by highlighting the prevalence and impact of diabetic neuropathy, emphasizing the urgent need for effective management strategies. It then outlines the multifaceted nature of diabetic neuropathy, encompassing sensory, motor, and autonomic neuropathies, each with its unique clinical manifestations and challenges. Next, the abstract delves into the diverse array of risk factors contributing to the development and progression of diabetic neuropathy, including hyperglycemia, dyslipidemia, oxidative stress, and inflammation. It underscores the importance of glycemic control as the cornerstone of management while acknowledging the significance of addressing other modifiable risk factors. The abstract proceeds to elucidate the pivotal role of lifestyle modifications in combating diabetic neuropathy, advocating for regular exercise, a balanced diet, smoking cessation, and alcohol moderation. It emphasizes the significance of patient education and self-management in fostering adherence to these lifestyle changes. Furthermore, the abstract explores the pharmacological interventions available for the symptomatic relief and disease modification of diabetic neuropathy, including oral medications, topical agents, and novel therapeutic modalities. It discusses the evidence-based guidelines for pharmacotherapy while acknowledging the limitations and potential side effects associated with certain medications. In addition to conventional therapies, the abstract highlights emerging treatments such as nerve growth factor modulators, antioxidants, and neuroprotective agents, underscoring the promise of ongoing research in elucidating novel therapeutic targets. Moreover, the abstract underscores the importance of a multidisciplinary approach to diabetic neuropathy management, involving collaboration among endocrinologists, neurologists, podiatrists, dietitians, and other healthcare professionals. It advocates for personalized care plans tailored to individual patient needs and preferences.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Diabetes.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Diabetes
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Stodt Jan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels